Author:
Xia Shu,Yu Shiying,Fu Qiang,Liu Fei,Zheng Wei,Fu Xiugen,Zhao Yin
Publisher
Springer Science and Business Media LLC
Subject
Genetics,Biomedical Engineering,Biomaterials,Biochemistry
Reference23 articles.
1. Jin ZH, Kurosu T, Yamaguchi M, et al. Hematopoietic cytokines enhance Chk1-dependent G2/M checkpoint activation by etoposide through the Akt/GSK3 pathway to inhibit apoptosis. Oncogene, 2005,24(12):1973–1981
2. Cheng JQ, Lindsley CW, Cheng GZ, et al. The Akt/PKB pathway: molecular target for cancer drug discovery. Oncogene, 2005,24(50):7482–7492
3. Opel D, Westhoff MA, Bender A, et al. Phosphatidylinositol 3-kinase inhibition broadly sensitizes glioblastoma cells to death receptor- and drug-induced apoptosis. Cancer Res, 2008,68(15):6271–6280
4. Okumura E, Fukuhara T, Yoshida H, et al. Akt inhibits Myt1 in the signalling pathway that leads to meiotic G2/M-phase transition. Nat Cell Biol, 2002,4(2): 111–116
5. Han R. The application of quantitative analysis of drugs’synergetic and antagonism effect. In: Zhou TC, Han R, Xu B. Chemoprevention and pharmacotherapy of tumor. Beijing: Peking Union Medical College Press, 1991:315–320
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献